| EPB0177 | The identification of intact HIV proviral DNA in human cerebrospinal fluid | E-poster | Co-morbidities |
| EPB0176 | Increase in ambient air pollution is associated with cardiovascular disease risk in youth with and without HIV in urban Uganda | E-poster | Co-morbidities |
| EPB0175 | Sociodemographic and HIV care correlates of substance use and symptoms of mental disorders among PWH aged >40 years in low- and middle-income countries in the Sentinel Research Network of IeDEA | E-poster | Co-morbidities |
| EPB0174 | Psychiatric multimorbidity among people with HIV aged >40 years in low- and middle-income countries in the Sentinel Research Network of IeDEA | E-poster | Co-morbidities |
| EPB0173 | Antiretroviral treatment as a protective factor for dysplasia and HPV infection in people living with HIV (PLHIV) | E-poster | Co-morbidities |
| EPB0172 | Early outcomes of successful integration of mental health screening into routine HIV care in Malawi | E-poster | Co-morbidities |
| EPB0171 | A pilot randomized controlled trial to improve depression and HIV care engagement among perinatal women with HIV in Malawi | E-poster | Co-morbidities |
| EPB0170 | Ambulatory blood pressure abnormalities and its determinants in people living with HIV and AIDS in an African setting | E-poster | Co-morbidities |
| EPB0169 | Selected comorbidities and the risk of ART switch in the context of HIV-RNA suppressed to ≤50 copies/mL | E-poster | Co-morbidities |
| EPB0168 | Changes in weight after switching from ritonavir-boosted protease inhibitors to dolutegravir/tenofovir alafenamide/emtricitabine: results from a single arm, open-label, phase 3 clinical trial study (SPIRITED) | E-poster | Co-morbidities |